These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 22834871)

  • 1. Impact of elevated intact parathyroid hormone on mortality and renal disease progression in patients with chronic kidney disease stages 3 and 4.
    Asche CV; Marx SE; Kim J; Unni SK; Andress D
    Curr Med Res Opin; 2012 Sep; 28(9):1527-36. PubMed ID: 22834871
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Plasma parathyroid hormone level and prevalent cardiovascular disease in CKD stages 3 and 4: an analysis from the Kidney Early Evaluation Program (KEEP).
    Bhuriya R; Li S; Chen SC; McCullough PA; Bakris GL
    Am J Kidney Dis; 2009 Apr; 53(4 Suppl 4):S3-10. PubMed ID: 19285609
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Parathyroid hormone, vitamin D, renal dysfunction, and cardiovascular disease: dependent or independent risk factors?
    Anderson JL; Vanwoerkom RC; Horne BD; Bair TL; May HT; Lappé DL; Muhlestein JB
    Am Heart J; 2011 Aug; 162(2):331-339.e2. PubMed ID: 21835295
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Elevated parathyroid hormone predicts mortality in dialysis patients undergoing valve surgery.
    Yan H; Sharma J; Weber CJ; Guyton RA; Perez S; Thourani VH
    Surgery; 2011 Dec; 150(6):1095-101. PubMed ID: 22136827
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dialysis vintage and parathyroid hormone level, not fibroblast growth factor-23, determines chronic-phase phosphate wasting after renal transplantation.
    Tomida K; Hamano T; Ichimaru N; Fujii N; Matsui I; Nonomura N; Tsubakihara Y; Rakugi H; Takahara S; Isaka Y
    Bone; 2012 Oct; 51(4):729-36. PubMed ID: 22796419
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Obesity is associated with increased parathyroid hormone levels independent of glomerular filtration rate in chronic kidney disease.
    Saab G; Whaley-Connell A; McFarlane SI; Li S; Chen SC; Sowers JR; McCullough PA; Bakris GL;
    Metabolism; 2010 Mar; 59(3):385-9. PubMed ID: 19800639
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Variability and risk factors for kidney disease progression and death following attainment of stage 4 CKD in a referred cohort.
    Levin A; Djurdjev O; Beaulieu M; Er L
    Am J Kidney Dis; 2008 Oct; 52(4):661-71. PubMed ID: 18805347
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intact parathyroid hormone levels in renal transplant patients with normal transplant function.
    Bleskestad IH; Bergrem H; Leivestad T; Gøransson LG
    Clin Transplant; 2011; 25(5):E566-70. PubMed ID: 21955131
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chronic Kidney Disease Epidemiology Collaboration versus Modification of Diet in Renal Disease equations for renal function evaluation in patients undergoing partial nephrectomy.
    Shikanov S; Clark MA; Raman JD; Smith B; Kaag M; Russo P; Wheat JC; Wolf JS; Huang WC; Shalhav AL; Eggener SE
    J Urol; 2010 Nov; 184(5):1867-71. PubMed ID: 20846677
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Calcium, phosphorus, PTH and death rates in a large sample of dialysis patients from Latin America. The CORES Study.
    Naves-Díaz M; Passlick-Deetjen J; Guinsburg A; Marelli C; Fernández-Martín JL; Rodríguez-Puyol D; Cannata-Andía JB
    Nephrol Dial Transplant; 2011 Jun; 26(6):1938-47. PubMed ID: 20513773
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Estimated glomerular filtration rate and prognosis in heart failure: value of the Modification of Diet in Renal Disease Study-4, chronic kidney disease epidemiology collaboration, and cockroft-gault formulas.
    Zamora E; Lupón J; Vila J; Urrutia A; de Antonio M; Sanz H; Grau M; Ara J; Bayés-Genís A
    J Am Coll Cardiol; 2012 May; 59(19):1709-15. PubMed ID: 22554602
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Decline in glomerular filtration rate during pre-dialysis phase and survival on chronic renal replacement therapy.
    Haapio M; Helve J; Kurimo P; Forslund T; Grönhagen-Riska C; Finne P
    Nephrol Dial Transplant; 2012 Mar; 27(3):1157-63. PubMed ID: 21810761
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Increased risk of mortality in the elderly population with late-stage chronic kidney disease: a cohort study in Taiwan.
    Hwang SJ; Lin MY; Chen HC; Hwang SC; Yang WC; Hsu CC; Chiu HC; Mau LW
    Nephrol Dial Transplant; 2008 Oct; 23(10):3192-8. PubMed ID: 18450830
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Validation of the Chronic Kidney Disease Epidemiology Collaboration (CKD-EPI) equation in advanced chronic renal failure.
    Teruel Briones JL; Gomis Couto A; Sabater J; Fernández Lucas M; Rodríguez Mendiola N; Villafruela JJ; Quereda C
    Nefrologia; 2011; 31(6):677-82. PubMed ID: 22130283
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bone metabolism according to chronic kidney disease stages in patients undergoing kidney transplantation: a 5-year database analysis.
    Fernández-Fresnedo G; Rodrigo E; Ruiz JC; Martín de Francisco AL; Arias M
    Transplant Proc; 2009; 41(6):2403-5. PubMed ID: 19715933
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A long-term, multicenter study of the efficacy and safety of paricalcitol in end-stage renal disease.
    Lindberg J; Martin KJ; González EA; Acchiardo SR; Valdin JR; Soltanek C
    Clin Nephrol; 2001 Oct; 56(4):315-23. PubMed ID: 11680662
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Adherence to K/DOQI bone metabolism guidelines.
    Smith DH; Johnson ES; Thorp ML; Yang X
    J Ren Nutr; 2009 Jul; 19(4):334-42. PubMed ID: 19539186
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Third-generation parathyroid hormone assays and all-cause mortality in incident dialysis patients: the CHOICE study.
    Melamed ML; Eustace JA; Plantinga LC; Jaar BG; Fink NE; Parekh RS; Coresh J; Yang Z; Cantor T; Powe NR
    Nephrol Dial Transplant; 2008 May; 23(5):1650-8. PubMed ID: 18065788
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of the Modification of Diet in Renal Disease and Cockcroft-Gault equations for dosing antimicrobials.
    Hermsen ED; Maiefski M; Florescu MC; Qiu F; Rupp ME
    Pharmacotherapy; 2009 Jun; 29(6):649-55. PubMed ID: 19476418
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of dietary protein restriction on the progression of kidney disease: long-term follow-up of the Modification of Diet in Renal Disease (MDRD) Study.
    Levey AS; Greene T; Sarnak MJ; Wang X; Beck GJ; Kusek JW; Collins AJ; Kopple JD
    Am J Kidney Dis; 2006 Dec; 48(6):879-88. PubMed ID: 17162142
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.